Although T2DM is a metabolic disorder resulting from both β-cell dysfunction (with altered insulin levels) and impaired insulin action (insulin resistance), there is no evidence of human leukocyte antigen (HLA) markers or autoantibodies activity [4]. The gene discussed is INS; the disease is metabolic disease.